CLLS Cellectis

Watchlist

2.560
0.0000.00%

Close Apr 30 16:00 ET

184.20MMarket Cap-1446P/E (TTM)

About Cellectis Company

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Company Profile

SymbolCLLS

Company NameCellectis

Listing DateMar 25, 2015

Issue Price36.83

Founded1999

CEODr. Andre Choulika

MarketNASDAQ

Employees285

Securities TypeDR

ADS Ratio1.0 : 1.0

Fiscal Year Ends12-31

Address8, rue de la Croix Jarry

CityParis

ProvinceIle-de-France

CountryFrance

Zip Code75013

Phone33-1-81-69-16-00

Websitehttp://www.cellectis.com

Company Executives

Name
Position
Salary

Dr. David Sourdive
Director, Deputy Chief Executive Officer and Executive Vice President, CMC and Manufacturing
657.84K

Dr. Andre Choulika
Director and Chief Executive Officer
1.13M

Bing Wang, PhD
Chief Financial Officer
--

Stephan Reynier
Chief Regulatory and Pharmaceutical Compliance Officer
--

Philippe Duchateau, PhD
Chief Scientific Officer
--

Arthur Stril
Chief Business Officer
--

Kyung Nam-Wortman
Executive Vice President and Chief Human Resources Officer
--

Dr. Mark Frattini, M.D.,PhD
Chief Medical Officer
--

Dr. Steven Doares, PhD
Senior Vice President, US Manufacturing
--

Dr. Jean-Pierre Garnier, PhD
Chairman of the Board
203.80K

Laurent Arthaud
Director
--

Cecile Chartier
Independent Director
47.77K

Pierre Tristan Michel Bastid
Independent Director
97.34K

Axel-Sven Malkomes
Independent Director
102.75K

Dr. Donald A. Bergstrom, M.D.,PhD
Independent Director
102.75K

Rainer J. Boehm, M.B.A.
Independent Director
99.60K

Marie-Bleuenn Terrier
General Counsel
--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall